NEWS
2025年09月09日
iCONM in collaboration with BioLabsでは、9月25日（木）8 amより、BioLabsと共同でウェビナー「How to Launch a Biotech?」を開催します。ぜひご参加ください。
これから創薬スタートアップを設立するときに何をすれば良いか考えるかと思います。
そういう時は、本ウェビナーに参加してベンチャーキャピタル(VC)、製薬企業、大学でのイノベーション支援者の様々な立場のパネリストに何をすべきかのチェックリストを聞いてみましょう。創薬系起業家が、新たにスタートアップを始めるためのToDoを把握し、初期段階でのよくある失敗を減らし、落とし穴に入り込まずに少しでも成功へ近づけていくことを目指します。
How to Launch a Biotech?
Ready to Launch Your Biotech? Join iCONM in collaboration with BioLabs for an engaging panel discussion on the first steps to starting a biotech company. Whether you’re an academic researcher with a promising discovery or an early-stage startup founder seeking to position your company to attract strategic partnership and/or venture capital, this session will demystify what it takes to move from idea to commercialization. Hear directly from technology transfer experts, big pharma business development/venture professionals, and leading venture as they share the checklist investors and pharma teams use to evaluate new technologies—and what you should consider when working with your Technology Transfer Office (TTO). Moderated by BioLabs, this conversation will give you practical insights to take your first steps to scaling your biotech startup with confidence.
When
Thu 8-9am, Sep. 25 in JST (Wed 7-8pm, Sep. 24 in EDT)
Language
English
Fee
Free
Panelists
Shann Yu, AbbVie Ventures
Shann is a globally minded strategic thinker whose training in bioengineering and immunology took him across three continents. He joined AbbVie as part of the Strategic Leadership Program, where he gained experience in business development, decision sciences, and pipeline analytics prior to joining AbbVie Ventures. Shann is passionate about enabling complete cures and improving the lives of patients through innovative science.
Chaya Patel, Mission BioCapital
Chaya D. Patel, PhD is a Principal in our Cambridge office, where she identifies and evaluates new investment opportunities and provides support to our portfolio companies through operational roles. Since joining our firm in 2021, Chaya has supported our investments in Arclight Therapeutics, ImmunOs, and Eikonizo Therapeutics through Board Observer roles. She is also active in the Boston venture ecosystem as a leader for the Emerging Venture Capitalists Association (EVCA). Prior to joining us, she was focused on venture creation at a family office, contributing to the development of Alloy Therapeutics. Chaya earned her PhD from Dartmouth, where her research advanced the understanding of creating maternal immunity to prevent neonatal viral infections. She received her B.S. in Microbiology and Immunology from UCLA.
Ryosuke Munakata, Keio University
Chaya D. Patel, PhD is a Principal in our Cambridge office, where she identifies and evaluates new investment opportunities and provides support to our portfolio companies through operational roles. Since joining our firm in 2021, Chaya has supported our investments in Arclight Therapeutics, ImmunOs, and Eikonizo Therapeutics through Board Observer roles. She is also active in the Boston venture ecosystem as a leader for the Emerging Venture Capitalists Association (EVCA). Prior to joining us, she was focused on venture creation at a family office, contributing to the development of Alloy Therapeutics. Chaya earned her PhD from Dartmouth, where her research advanced the understanding of creating maternal immunity to prevent neonatal viral infections. She received her B.S. in Microbiology and Immunology from UCLA.
Moderator
Laura Stevens, BioLabs
iCONM in collaboration with BioLabsについて
iCONM in collaboration with BioLabsは、羽田空港の対岸に位置する川崎市殿町キングスカイフロントにある「ナノ医療イノベーションセンター（iCONM）」内にある、ライフサイエンス分野のスタートアップを支援するインキュベーション施設です。日本の高い研究技術力に 対して、iCONMの研究支援環境と米国ボストンにあるバイオ領域のグローバルインキュベーター BioLabsの社会実装支援経験の強みをかけ合わせ、スタートアップを支援します。iCONM in collaboration with BioLabsでは、 370種類を超える、微細加工・化学合成・バイオ・動物実験系の共用機器を備えています。【入居者募集中・詳細はこちら】